{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:17:50Z","timestamp":1770675470965,"version":"3.49.0"},"reference-count":62,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2014.00223","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T13:30:15Z","timestamp":1412861415000},"source":"Crossref","is-referenced-by-count":34,"title":["Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta"],"prefix":"10.3389","volume":"5","author":[{"given":"Jerry K. Y.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"G\u00c3\u00b6therstr\u00c3\u00b6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1634\/stemcells.2006-0762","article-title":"Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung","volume":"25","author":"Aguilar","year":"2007","journal-title":"Stem Cells"},{"key":"B2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","article-title":"Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta","volume":"86","author":"Alanay","year":"2010","journal-title":"Am. J. Hum. Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0022-3476(96)70077-X","article-title":"Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis","volume":"129","author":"Antoniazzi","year":"1996","journal-title":"J. Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/EJE-10-0208","article-title":"GH in combination with bisphosphonate treatment in osteogenesis imperfecta","volume":"163","author":"Antoniazzi","year":"2010","journal-title":"Eur. J. Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12434","article-title":"Fetal skeletal dysplasias in a tertiary care center: radiology, pathology, and molecular analysis of 112 cases","author":"Barkova","year":"2014","journal-title":"Clin. Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1056\/NEJMoa0907705","article-title":"Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding","volume":"362","author":"Barnes","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","article-title":"Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow","volume":"98","author":"Campagnoli","year":"2001","journal-title":"Blood"},{"issue":"(Pt 7)","key":"B8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/jcs.01731","article-title":"Procollagen trafficking, processing and fibrillogenesis","volume":"118","author":"Canty","year":"2005","journal-title":"J. Cell Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1126\/science.1088757","article-title":"Gene targeting in stem cells from individuals with osteogenesis imperfecta","volume":"303","author":"Chamberlain","year":"2004","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/humrep\/den302","article-title":"First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells","volume":"23","author":"Chan","year":"2008","journal-title":"Hum. Reprod"},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1634\/stemcells.2004-0138","article-title":"Human fetal mesenchymal stem cells as vehicles for gene delivery","volume":"23","author":"Chan","year":"2005","journal-title":"Stem Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1634\/stemcells.2005-0564","article-title":"Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration","volume":"24","author":"Chan","year":"2006","journal-title":"Stem Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1634\/stemcells.2006-0694","article-title":"Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse","volume":"25","author":"Chan","year":"2007","journal-title":"Stem Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1479-5876-12-8","article-title":"Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation","volume":"12","author":"Choudhery","year":"2014","journal-title":"J. Transl. Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","article-title":"Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta","volume":"86","author":"Christiansen","year":"2010","journal-title":"Am. J. Hum. Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"(Pt 11)","key":"B18","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J. Cell Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nbt1274","article-title":"Isolation of amniotic stem cell lines with potential for therapy","volume":"25","author":"De Coppi","year":"2007","journal-title":"Nat. Biotechnol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1365-2141.1999.01715.x","article-title":"Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate","volume":"107","author":"Digirolamo","year":"1999","journal-title":"Br. J. Haematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0234","article-title":"Immune regulatory properties of CD117pos amniotic fluid stem cells vary according to gestational age","author":"Di Trapani","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"CD005088","DOI":"10.1002\/14651858.CD005088.pub3","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"7","author":"Dwan","year":"2014","journal-title":"Cochrane Database Syst. Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","article-title":"New perspectives on osteogenesis imperfecta","volume":"7","author":"Forlino","year":"2011","journal-title":"Nat. Rev. Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/mgme.2000.3039","article-title":"Osteogenesis imperfecta: prospects for molecular therapeutics","volume":"71","author":"Forlino","year":"2000","journal-title":"Mol. Genet. Metab"},{"key":"B26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"B27","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J. Embryol. Exp. Morphol"},{"issue":"(Suppl.)","key":"B28","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/01.tp.0000269200.67707.c8","article-title":"Immunomodulation by multipotent mesenchymal stromal cells","volume":"84","author":"Gotherstrom","year":"2007","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ajog.2003.07.022","article-title":"Immunologic properties of human fetal mesenchymal stem cells","volume":"190","author":"Gotherstrom","year":"2004","journal-title":"Am. J. Obstet. Gynecol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.bmt.1704318","article-title":"Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells","volume":"32","author":"Gotherstrom","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5966\/sctm.2013-0090","article-title":"Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience","volume":"3","author":"Gotherstrom","year":"2014","journal-title":"Stem Cells Transl. Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2007-08-105809","article-title":"Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice","volume":"111","author":"Guillot","year":"2008","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1634\/stemcells.2006-0208","article-title":"Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC","volume":"25","author":"Guillot","year":"2007","journal-title":"Stem Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat. Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","article-title":"Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta","volume":"97","author":"Horwitz","year":"2001","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.exphem.2004.02.004","article-title":"Mesenchymal stem cells: paradoxes of passaging","volume":"32","author":"Javazon","year":"2004","journal-title":"Exp. Hematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.4161\/cc.8.7.8121","article-title":"Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype","volume":"8","author":"Kennea","year":"2009","journal-title":"Cell Cycle"},{"key":"B39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ocl.2013.06.010","article-title":"Advances in the orthopedic management of osteogenesis imperfecta","volume":"44","author":"Laron","year":"2013","journal-title":"Orthop. Clin. North Am"},{"key":"B40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Cytotherapy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrendo.2009.58","article-title":"Bone: use of bisphosphonates in children-proceed with caution","volume":"5","author":"Marini","year":"2009","journal-title":"Nat. Rev. Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bpobgyn.2012.06.005","article-title":"The case for intrauterine stem cell transplantation","volume":"26","author":"Mattar","year":"2012","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/hmg\/11.19.2201","article-title":"Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta","volume":"11","author":"Millington-Ward","year":"2002","journal-title":"Hum. Mol. Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/hmg\/6.9.1415","article-title":"Strategems in vitro for gene therapies directed to dominant mutations","volume":"6","author":"Millington-Ward","year":"1997","journal-title":"Hum. Mol. Genet"},{"issue":"(Pt 7)","key":"B48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1242\/jcs.113.7.1161","article-title":"Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model","volume":"113","author":"Muraglia","year":"2000","journal-title":"J. Cell Sci"},{"key":"B49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/157488806778226768","article-title":"Human fetal mesenchymal stem cells","volume":"1","author":"O\u00e2\u20ac\u2122Donoghue","year":"2006","journal-title":"Curr. Stem Cell Res. Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1182\/blood-2011-12-400085","article-title":"Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms","volume":"120","author":"Otsuru","year":"2012","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/blood-2008-12-195859","article-title":"In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta","volume":"114","author":"Panaroni","year":"2009","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1073\/pnas.92.11.4857","article-title":"Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice","volume":"92","author":"Pereira","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11914-996-0025-2","article-title":"Treatment of children with osteogenesis imperfecta","volume":"4","author":"Rauch","year":"2006","journal-title":"Curr. Osteoporos. Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","article-title":"Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment","volume":"131","author":"Sacchetti","year":"2007","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/uog.6359","article-title":"Prenatal sonographic diagnosis of skeletal dysplasias","volume":"34","author":"Schramm","year":"2009","journal-title":"Ultrasound Obstet. Gynecol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1741-7015-11-146","article-title":"Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells","volume":"11","author":"Siegel","year":"2013","journal-title":"BMC Med"},{"key":"B58","first-page":"813","article-title":"Morphologic studies in the skeletal dysplasias","volume":"96","author":"Sillence","year":"1979","journal-title":"Am. J. Pathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.coi.2010.10.012","article-title":"Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?","volume":"22","author":"Uccelli","year":"2010","journal-title":"Curr. Opin. Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1634\/stemcells.2008-0456","article-title":"Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells","volume":"27","author":"Zhang","year":"2009","journal-title":"Stem Cells"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.biomaterials.2011.12.025","article-title":"The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:53:38Z","timestamp":1650390818000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2014.00223\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":62,"URL":"https:\/\/doi.org\/10.3389\/fphar.2014.00223","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]}}}